NASDAQ

Geron Corporation (GERN)

464 Thanks from members

Geron Corporation (GERN) displays mixed market sentiment, balancing better-than-expected Q1 2026 earnings and high potential upside targets against recent downward stock pressure, shifting price targets, and key technical support testing.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →